Medical News

RSS

Depressed pregnant women at increased risk of delivering preterm birth and low-birth weight infants

Clinical depression puts pregnant women at increased risk of delivering prematurely and of giving birth to below-normal weight infants, according to a report published Oct. 4 in the Archives of General Psychiatry.

5 Oct 2010

Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.

5 Oct 2010

FDA grants marketing clearance for EarlySense's EverOn Central Display Station

EarlySense announced today that its EverOn Central Display Station (CDS) has been cleared for marketing by the U.S. Food and Drug Administration (FDA). The FDA clearance covers the ability of the system to collect real time vital sign information from up to 36 EverOn bedside monitors and display the information on a computer screen at the nurse's station.

5 Oct 2010

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Oct 2010

Study could lead to new therapies for acute muscle injury

A new research study published in The FASEB Journal may change how sports injuries involving muscle tissue are treated, as well as how much patient monitoring is necessary when potent anti-inflammatory drugs are prescribed for a long time. That's because the study shows for the first time that inflammation actually helps to heal damaged muscle tissue, turning conventional wisdom on its head that inflammation must be largely controlled to encourage healing.

5 Oct 2010

Classical singing compared to traditional Indian singing to find treatment for speech disorder

Hindustani singing, a North Indian traditional style of singing, and classical singing, such as the music of Puccini, Mozart and Wagner, vary greatly in technique and sound. Now, speech-language pathology researchers at the University of Missouri are comparing the two styles in hopes of finding a treatment for laryngeal tremors, a vocal disorder associated with many neurological disorders that can result in severe communication difficulties.

5 Oct 2010

Researchers discover therapy for treating terminal stages of cancer

For the first time ever, researchers have discovered a therapy that can effectively treat the now invariably lethal, terminal stages of cancer in animals. The study appears in the latest issue of the Proceedings of the National Academy of Sciences.

5 Oct 2010

New bill aims to promote federal agency collaboration on foreign aid, national security

House lawmakers recently introduced the 2010 Interagency National Security Professional Education, Administration and Development System Act in an effort to promote better "collaboration among federal agencies supporting security missions and foreign aid operations overseas," Government Executive reports.

5 Oct 2010

$Osseon receives second patent NOA for spinal vertebral compression fracture technology$

Osseon receives second patent NOA for spinal vertebral compression fracture technology

Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.

5 Oct 2010

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 million to $1.5 million but denied Merck's request for judgment in its favor or a new trial in the case of Boles v. Merck, a retrial of a federal FOSAMAX case.

5 Oct 2010

Media examines PEPFAR hearing, calls for more HIV funding ahead of Global Fund replenishment meeting

Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.

5 Oct 2010

Human growth hormone can treat cystic fibrosis symptoms

Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by HHS' Agency for Healthcare Research and Quality (AHRQ).

5 Oct 2010

Researchers identify new type of cell that protects from immune system attack

Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.

5 Oct 2010

CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc. a drug discovery and development biopharmaceutical company, has announced that Dr. William Schmidt, its Vice President of Clinical Development, has been invited to present a talk on Development of CG100649, Tissue-selective Dual Inhibitor of COX-2 and Carbonic Anhydrase for Treatment of Osteoarthritis at Arrowhead's upcoming 4th Annual Pain Therapeutics Summit, to be held on October 4-5, 2010 in Philadelphia.

5 Oct 2010

African leaders to meet in Zambia to discuss country responses to HIV/AIDS

Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.

5 Oct 2010

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Neuro-Biotech Corporation introduces a Neuro-biomarker which is linked to a series of Neuro-Bio tests. This will permit to understand the science behind them and how they each will contribute to a progressive clinical investigation involving the input and output of the brain.

5 Oct 2010

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor (BDNF), a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (PNES) (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

CPS recommends all Canadian babies should be vaccinated against rotavirus

All Canadian babies should be vaccinated against rotavirus, according to a new statement by the Canadian Paediatric Society. The CPS is also calling for public funding of the vaccine, which is not currently covered by provincial or territorial health plans.

5 Oct 2010

U.S. Social Security Administration selects Accenture to implement emerging technology applications

The U.S. Social Security Administration (SSA) has selected Accenture as a prime contractor under the Information Technology Support Services Contract (ITSSC) that will be used to acquire a wide range of IT systems development and modernization services. The ITSSC includes a one-year base period plus six additional one-year options with an aggregate ceiling valued at $2.8 billion.

5 Oct 2010

FDA approves Food Contact Notification for CDG Solution 3000

The FDA notified CDG Environmental, LLC on September 29th of its approval of Food Contact Notification FCN 001011 for CDG Solution 3000 effective October 28, 2010.

5 Oct 2010

Medical News

Depressed pregnant women at increased risk of delivering preterm birth and low-birth weight infants

Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

FDA grants marketing clearance for EarlySense's EverOn Central Display Station

Study supports therapeutic potential of deep brain stimulation in patients with chronic psychiatric disorders

Study could lead to new therapies for acute muscle injury

Classical singing compared to traditional Indian singing to find treatment for speech disorder

Researchers discover therapy for treating terminal stages of cancer

New bill aims to promote federal agency collaboration on foreign aid, national security

Osseon receives second patent NOA for spinal vertebral compression fracture technology

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Media examines PEPFAR hearing, calls for more HIV funding ahead of Global Fund replenishment meeting

Human growth hormone can treat cystic fibrosis symptoms

Researchers identify new type of cell that protects from immune system attack

CrystalGenomics to present Phase I MAD study data at Arrowhead Summit

African leaders to meet in Zambia to discuss country responses to HIV/AIDS

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

CPS recommends all Canadian babies should be vaccinated against rotavirus

U.S. Social Security Administration selects Accenture to implement emerging technology applications

FDA approves Food Contact Notification for CDG Solution 3000

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News